KNCV Knowledge Institute

The KNCV Knowledge Institute brings together the research and innovation expertise within our network. The Knowledge Institute aims to showcase our track record in research and innovation related to TB-associated health issues, and health systems.

KNCV Knowledge Institute objectives

The KNCV Knowledge Institute objectives are:

  1. To ensure that KNCV-supported innovations are at the forefront of research and development in the field, with a focus on quality assurance. Any innovations that prove to be effective will be effectively communicated and widely applied across KNCV-supported countries and beyond. This will facilitate national, regional, or global scale, as appropriate.
  2. To formalize relationships with universities and training institutes, to ensure that they are mutually beneficial and promote clear knowledge transfer. This involves consolidating and structuring the KNCV internship and exchange program. This will enhance KNCV’s expertise in TB and related health issues and support the development of future leaders in the field.

To establish KNCV as a reference centre for TB research, innovation, and project implementation, we are undertaking a systematic effort to raise awareness of our existing resources.

 

KNCV Knowledge Institute expected outcomes by 2025:

  • KNCV-supported research and innovations are easily accessible and visible on the KNCV websites worldwide and in KNCV communications
  • KNCV research network mapped, clearly displayed on KNCV websites worldwide and up to date
  • KNCV alumni network formed and engaged for dissemination and feedback
  • KNCV Knowledge Institute newsletter published at least twice a year and disseminated across KNCV worldwide, the KNCV research network and partners
  • All study protocols are reviewed by the KNCV ERB
  • The proceedings of KNCV ERB meetings are systematically documented
  • A social scientist involved in all qualitative research at KNCV 

 

More information

Read more about our Ethical Review Board (ERB), our Experts and our Publications.

Read more

  • 01/11/2016

    Visit Director of Communicable Diseases Indonesia

    Dr. Wiendra Waworuntu, Director of Communicable Diseases at the MOH of Indonesia is visiting with KNCV in the Hague this…

    Lees meer
  • 13/10/2016

    Growing evidence of extent and threat of global tuberculosis crisis

    The Hague, 13 October 2016 – Data released today by the World Health Organization (WHO) in its Global…

    Lees meer
  • Thank you!

    Thank you for subscribing to our newsletter. We will sent you a confirmation mail.

    Lees meer
  • Thanks!

    Thank you for applying to our vacancy. We will get in touch with you shortly.

    Lees meer
  • 23/09/2016

    On childhood TB, stigma, and listening to care givers in Botswana

    In a thought-provoking editorial KNCV’s Dr. Ellen Mitchell reflects on an article by Stillson and colleagues on ‘Exploring challenges faced…

    Lees meer
  • The heart-wrenching personal story of Loyce

    Loyce Maturu from Zimbabwe visited the Netherlands on her way to Canada to address the Global…

    Lees meer
  • 19/09/2016

    WHO launches Target Regimen Profiles for TB treatment

    Anti-TB drug research and development is focusing increasingly on testing TB drug regimens rather than on individual drugs. The development…

    Lees meer
  • Electronic surveillance in Vietnam

    Vietnam has developed an electronic surveillance system for recording and accessing information about TB patients and TB treatment results. The…

    Lees meer
  • Jan Voskens

    The KNCV team in Indonesia made this memorabilia video for Pak Jan:…

    Lees meer
  • Meet Herry Sutanto, 34 years old.

    Although his wife left him after he was diagnosed with drug-resistant tuberculosis (TB), Herry does not give up and still…

    Lees meer
  • 24/08/2016

    Jan Voskens (1952-2016)

    His compassion and genuine interest in people were characteristic of his work as a TB…

    Lees meer
  • 21/07/2016

    TB screening and diagnosis in Indonesian prisons

    A Memorandum of Understanding has been signed with the Ministry of Law and Human Rights in Indonesia for active TB…

    Lees meer
  • 30/06/2016

    The European Commission’s 3rd Health Program co-funds E-DETECT.

    KNCV is one of the partners in E-DETECT (early detection and integrated management of tuberculosis in Europe), a project that…

    Lees meer
  • 28/06/2016

    KNCV and European partners request Sanofi to take steps to register rifapentine with the EMA

    KNCV Tuberculosis Foundation and European partners request Sanofi to take steps to register rifapentine (Priftin®) with the European…

    Lees meer
  • 10/06/2016

    KNCV Annual Report 2015

    In 2015 KNCV Tuberculosis Foundation was active in more than 25 countries in Europe, Africa and Central and South East…

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.